Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 298

1.

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Blondeaux E, Musio D, Bruzzi P, Lambertini M, Gazzola V, Poggio F, Vecchio S, Levaggi A, D'Alonzo A, Perfumo MC, Bighin C, Giraudi S, Palombo D, Del Mastro L.

Breast Cancer Res Treat. 2016 Sep 23. [Epub ahead of print]

PMID:
27663435
2.

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.

Gennari A, Amadori D, Scarpi E, Farolfi A, Paradiso A, Mangia A, Biglia N, Gianni L, Tienghi A, Rocca A, Maltoni R, Antonucci G, Bruzzi P, Nanni O.

Breast Cancer Res Treat. 2016 Aug;159(1):79-86. doi: 10.1007/s10549-016-3923-8. Epub 2016 Jul 26.

PMID:
27460638
3.

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.

Marini C, Cistaro A, Campi C, Calvo A, Caponnetto C, Nobili FM, Fania P, Beltrametti MC, Moglia C, Novi G, Buschiazzo A, Perasso A, Canosa A, Scialò C, Pomposelli E, Massone AM, Bagnara MC, Cammarosano S, Bruzzi P, Morbelli S, Sambuceti G, Mancardi G, Piana M, Chiò A.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2061-71. doi: 10.1007/s00259-016-3440-3. Epub 2016 Jul 15.

4.

Combined vemurafenib and fotemustine in patients with BRAFV600 melanoma progressing on vemurafenib.

Queirolo P, Spagnolo F, Picasso V, Spano L, Tanda E, Fontana V, Giorello L, Merlo DF, Simeone E, Grimaldi AM, Curvietto M, Del Vecchio M, Bruzzi P, Ascierto PA.

Oncotarget. 2016 Jul 13. doi: 10.18632/oncotarget.10589. [Epub ahead of print]

5.

SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes.

Tinterri C, Canavese G, Bruzzi P, Dozin B.

Breast. 2016 Jul 9. pii: S0960-9776(16)30090-X. doi: 10.1016/j.breast.2016.06.016. [Epub ahead of print]

PMID:
27406897
6.

Estimating a treatment effect: Choosing between relative and absolute measures.

Sormani MP, Bruzzi P.

Mult Scler. 2016 Apr 29. pii: 1352458516645671. [Epub ahead of print]

PMID:
27207463
7.

Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation.

Chiodi S, Spinelli S, Bruzzi P, Anserini P, Di Grazia C, Bacigalupo A.

J Obstet Gynaecol. 2016 May 6:1-6. [Epub ahead of print]

PMID:
27153290
8.

Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT.

Marini C, Seitun S, Zawaideh C, Bauckneht M, Morelli MC, Ameri P, Ferrarazzo G, Budaj I, Balbi M, Fiz F, Boccalini S, Pregliasco AG, Buschiazzo A, Saracco A, Bagnara MC, Bruzzi P, Brunelli C, Ferro C, Bezante GP, Sambuceti G.

J Nucl Cardiol. 2016 May 5. [Epub ahead of print]

PMID:
27151303
9.

Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature.

di Dio F, Mariotti I, Coccolini E, Bruzzi P, Predieri B, Iughetti L.

BMC Pediatr. 2016 May 3;16:62. doi: 10.1186/s12887-016-0595-9.

10.

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.

Griseri P, Garrone O, Lo Sardo A, Monteverde M, Rusmini M, Tonissi F, Merlano M, Bruzzi P, Lo Nigro C, Ceccherini I.

Oncotarget. 2016 May 3;7(18):26465-79. doi: 10.18632/oncotarget.8417.

11.

Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures.

Bertoglio S, Faccini B, Lalli L, Cafiero F, Bruzzi P.

J Surg Oncol. 2016 May;113(6):708-14. doi: 10.1002/jso.24220. Epub 2016 Mar 29.

PMID:
27020965
12.

Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.

Canavese G, Bruzzi P, Catturich A, Tomei D, Carli F, Garrone E, Spinaci S, Lacopo F, Tinterri C, Dozin B.

Ann Surg Oncol. 2016 Aug;23(8):2494-500. doi: 10.1245/s10434-016-5177-4. Epub 2016 Mar 14.

PMID:
26975739
13.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

Portier CJ, Armstrong BK, Baguley BC, Baur X, Belyaev I, Bellé R, Belpoggi F, Biggeri A, Bosland MC, Bruzzi P, Budnik LT, Bugge MD, Burns K, Calaf GM, Carpenter DO, Carpenter HM, López-Carrillo L, Clapp R, Cocco P, Consonni D, Comba P, Craft E, Dalvie MA, Davis D, Demers PA, De Roos AJ, DeWitt J, Forastiere F, Freedman JH, Fritschi L, Gaus C, Gohlke JM, Goldberg M, Greiser E, Hansen J, Hardell L, Hauptmann M, Huang W, Huff J, James MO, Jameson CW, Kortenkamp A, Kopp-Schneider A, Kromhout H, Larramendy ML, Landrigan PJ, Lash LH, Leszczynski D, Lynch CF, Magnani C, Mandrioli D, Martin FL, Merler E, Michelozzi P, Miligi L, Miller AB, Mirabelli D, Mirer FE, Naidoo S, Perry MJ, Petronio MG, Pirastu R, Portier RJ, Ramos KS, Robertson LW, Rodriguez T, Röösli M, Ross MK, Roy D, Rusyn I, Saldiva P, Sass J, Savolainen K, Scheepers PT, Sergi C, Silbergeld EK, Smith MT, Stewart BW, Sutton P, Tateo F, Terracini B, Thielmann HW, Thomas DB, Vainio H, Vena JE, Vineis P, Weiderpass E, Weisenburger DD, Woodruff TJ, Yorifuji T, Yu IJ, Zambon P, Zeeb H, Zhou SF.

J Epidemiol Community Health. 2016 Aug;70(8):741-5. doi: 10.1136/jech-2015-207005. Epub 2016 Mar 3. No abstract available.

14.

Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer.

Marini C, Bianchi G, Buschiazzo A, Ravera S, Martella R, Bottoni G, Petretto A, Emionite L, Monteverde E, Capitanio S, Inglese E, Fabbi M, Bongioanni F, Garaboldi L, Bruzzi P, Orengo AM, Raffaghello L, Sambuceti G.

Sci Rep. 2016 Jan 22;6:19569. doi: 10.1038/srep19569.

15.

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.

Del Mastro L, Levaggi A, Michelotti A, Cavazzini G, Adami F, Scotto T, Piras M, Danese S, Garrone O, Durando A, Accortanzo V, Bighin C, Miglietta L, Pastorino S, Pronzato P, Castiglione F, Landucci E, Conte P, Bruzzi P.

Breast Cancer Res Treat. 2016 Jan;155(1):117-26. doi: 10.1007/s10549-015-3655-1. Epub 2015 Dec 10.

PMID:
26661403
16.

Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma.

Bruzzi P, Sani I, Albanese A.

Horm Res Paediatr. 2015;84(6):414-22. doi: 10.1159/000440956. Epub 2015 Oct 22.

PMID:
26488470
17.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, Pentiricci S, Poggio D, Grillo M, Amigoni P, Iascone M, Mortara A, Maron BJ, Senni M, Bruzzi P.

J Am Coll Cardiol. 2015 Oct 13;66(15):1687-96. doi: 10.1016/j.jacc.2015.07.069.

PMID:
26449139
18.

[Health registries: methodological issues].

Bruzzi P.

Recenti Prog Med. 2015 Sep;106(9):436-43. doi: 10.1701/1996.21592. Italian.

PMID:
26418505
19.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L.

Ann Oncol. 2015 Dec;26(12):2408-19. doi: 10.1093/annonc/mdv374. Epub 2015 Sep 7. Review.

PMID:
26347105
20.

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.

Lambertini M, Bruzzi P, Poggio F, Pastorino S, Gardin G, Clavarezza M, Bighin C, Pronzato P, Del Mastro L.

Support Care Cancer. 2016 Mar;24(3):1285-94. doi: 10.1007/s00520-015-2907-2. Epub 2015 Aug 27.

PMID:
26306520
Items per page

Supplemental Content

Loading ...
Write to the Help Desk